64 Participants Needed

Passive Stretching for Peripheral Arterial Disease

JT
Overseen ByJacob T Caldwell, Ph.D.
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: University of Wisconsin, La Crosse
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment for Peripheral Arterial Disease?

Research shows that daily passive stretching of calf muscles can improve blood flow and walking ability in patients with peripheral arterial disease. Additionally, long-term passive stretching has been found to enhance vascular function and reduce arterial stiffness, which are important for cardiovascular health.12345

Is passive stretching safe for humans?

Research on passive stretching, often used in physical therapy, shows it is generally safe for humans, including older adults and those recovering from surgery, with no significant safety concerns reported in the studies.35678

How does passive stretching treatment for Peripheral Arterial Disease differ from other treatments?

Passive stretching is unique because it improves blood flow and reduces arterial stiffness by gently stretching muscles without active movement, which can enhance vascular function and flexibility. Unlike medications or surgical interventions, it is a non-invasive therapy that can be done regularly to improve circulation and muscle elasticity.235910

What is the purpose of this trial?

Peripheral artery disease (PAD) leads to higher mortality rates and strains healthcare systems due to increased costs. It causes leg pain during walking due to reduced blood flow. Nitric oxide (NO) deficiency contributes to vascular issues in PAD, with few effective treatments available. Passive calf muscle stretching boosts NO levels, vascular health, and walking ability in PAD patients. However, the inflammatory processes underlying these improvements are unclear. This study aims to track inflammatory markers and cardiovascular changes during 12 weeks of passive stretching. Additionally, combining stretching with dietary nitrate could further enhance walking capacity by reducing reactive oxygen species. The study will monitor inflammation, vascular function, and oxidative capacity to understand the effects on functional ability in PAD patients. This research is crucial for improving physical function and addressing exercise intolerance in PAD.

Research Team

JT

Jacob T Caldwell, Ph.D.

Principal Investigator

Assistant Professor

Eligibility Criteria

This trial is for individuals with Peripheral Arterial Disease (PAD), which causes leg pain and difficulty walking due to poor blood flow. Participants should be interested in exploring non-drug treatments like stretching and dietary changes to improve their condition.

Inclusion Criteria

Ankle-brachial index of 0.90 or less
My health condition has been stable for at least 3 months.

Exclusion Criteria

Beet allergy
I have kidney disease.
I have Crohn's disease.
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo passive stretching of the calf muscles 5 days per week for 12 weeks, combined with dietary nitrate to enhance walking capacity

12 weeks
5 visits per week (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments of functional capacity, inflammatory markers, and vascular function

2 weeks

Treatment Details

Interventions

  • Dietary Nitrate
  • Passive Stretching
Trial Overview The study tests if passive calf muscle stretching, possibly combined with dietary nitrate supplements, can increase nitric oxide levels, reduce inflammation, and enhance walking ability in PAD patients over a period of 12 weeks.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: InflammationExperimental Treatment2 Interventions
Blood and muscle biopsy samples pre/post passive stretching to assess local and systemic inflammation
Group II: Functional Walking capacityExperimental Treatment2 Interventions
Passive stretching of the calf muscles 5 days per week for 12-weeks

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Wisconsin, La Crosse

Lead Sponsor

Trials
5
Recruited
150+

Findings from Research

In a study involving 13 patients with peripheral arterial disease (PAD), daily passive calf muscle stretching for 4 weeks significantly improved endothelial function and walking ability, as measured by flow-mediated dilation (FMD) and the 6-minute walk test (6MWT).
The results showed that after stretching, FMD increased from 3.7% to 5.1% and walking distance improved from 182 meters to 304 meters, indicating that stretching can enhance blood flow and mobility in PAD patients.
Daily Passive Muscle Stretching Improves Flow-Mediated Dilation of Popliteal Artery and 6-minute Walk Test in Elderly Patients with Stable Symptomatic Peripheral Artery Disease.Hotta, K., Batchelor, WB., Graven, J., et al.[2020]
After 12 weeks of passive stretching training, participants showed significant improvements in vascular function and reduced arterial stiffness in both treated (femoral and popliteal) and untreated (brachial) arteries, indicating enhanced blood flow control mechanisms.
The benefits of passive stretching on vascular function were mostly temporary, as improvements related to central mechanisms returned to baseline within 6 weeks after training stopped, while local improvements persisted longer.
Evidence for improved systemic and local vascular function after long-term passive static stretching training of the musculoskeletal system.Bisconti, AV., Cè, E., Longo, S., et al.[2021]
In a study involving eight patients with esophageal cancer, unilateral passive stretching of the gastrocnemius muscle before and after surgery was shown to affect blood volume in the non-stretched (contralateral) muscle, indicating a potential systemic effect of localized stretching.
The results suggest that while the stretched muscle experienced changes in blood volume during stretching, the contralateral muscle exhibited an inversely synchronized response, highlighting the need for further investigation into the underlying mechanisms of this phenomenon.
Change in Contralateral Muscle Blood Volume During Passive Unilateral Muscle Stretching Before and After Surgery.Kutsuzawa, T., Matsumoto, H., Kurita, D., et al.[2021]

References

Daily Passive Muscle Stretching Improves Flow-Mediated Dilation of Popliteal Artery and 6-minute Walk Test in Elderly Patients with Stable Symptomatic Peripheral Artery Disease. [2020]
Evidence for improved systemic and local vascular function after long-term passive static stretching training of the musculoskeletal system. [2021]
Change in Contralateral Muscle Blood Volume During Passive Unilateral Muscle Stretching Before and After Surgery. [2021]
Passive leg movement enhances interstitial VEGF protein, endothelial cell proliferation, and eNOS mRNA content in human skeletal muscle. [2020]
Effects of an eight-week stretching program on the passive-elastic properties and function of the calf muscles of older women. [2022]
The acute effect of stretching on the passive stiffness of the human gastrocnemius muscle tendon unit. [2022]
Do practical durations of stretching alter muscle strength? A dose-response study. [2009]
The effect of prolonged static and cyclic stretching on ankle joint stiffness, torque relaxation, and gait in people with stroke. [2016]
Acute effect of passive one-legged intermittent static stretching on regional blood flow in young men. [2021]
10.Russia (Federation)pubmed.ncbi.nlm.nih.gov
[Changes in blood flow after longitudinal stretching of the cat m. gastrocnemius]. [2014]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security